Brest, Patrick http://orcid.org/0000-0002-1252-4747
Mograbi, Baharia
Hofman, Paul
Milano, Gerard http://orcid.org/0000-0003-2478-0040
Funding for this research was provided by:
Canceropôle PACA
Agence Nationale de la Recherche (ANR-15-IDEX-01, ANR-11-LABX-0028-01, ANR-15-IDEX-01, R19162DD, ANR-11-LABX-0028-01, ANR-15-IDEX-01)
CANC’AIR Genexposomic project, Canceropole PACA; DREAL PACA, ARS PACA, Région Sud, Children Medical Safety Research Institute
Article History
Received: 23 November 2020
Revised: 14 December 2020
Accepted: 17 December 2020
First Online: 3 February 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Not applicable.
: P.B., B.M. and P.H. declare no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years and no other relationships or activities that could appear to have influenced the submitted work. G.M. declares honorarium from BMS and Merck.
: This work was supported by French Government (Agence Nationale de Recherche, ANR) through the “Investments for the Future” LABEX SIGNALIFE [ANR-11-LABX-0028-01], IDEX UCAJedi ANR-15-IDEX-01, “Association pour la Recherche contre le Cancer” (GENEXPOSOMCS Canc’air), “Agence régionale santé Provence Alpes Côte d'Azur and Direction régionale de l’Environnement, de l’aménagement et du logement, Région SUD (I G: Région SUD, plan régional santé environnement, DREAL PACA, ARS PACA, PRSE PACA), Canceropole PACA; Institut National du Cancer; INSERM; INCA Plan Cancer; and Children Medical Safety Research Institute (CMSRI, Vaccinophagy project R17033DJA).